IBO
Impact BioMedical
18 hedge funds and large institutions have $305K invested in Impact BioMedical in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$144K | |
| 2 | +$19.9K | |
| 3 | +$17.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$15.2K |
| 5 |
Two Sigma Investments
New York
|
+$14.7K |
Top Sellers
| 1 | -$60.8K | |
| 2 | -$52.5K | |
| 3 | -$33.6K | |
| 4 |
Morgan Stanley
New York
|
-$6.79K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.5K |
